2023 Volume 163 Pages 117-122
We reviewed the data of 66 patients with parotid gland cancer who were treated by radical surgery. The 5-year overall survival (OS) rates according to the T classification were: T1: 100%; T2: 92.4%; T3: 56.1%; and T4: 68.1% (P = 0.082). The 5-year OS rates according to the disease Stage (St) classification were: St I: 100%; St II: 95.5%; St III: 88.9%; and St IV: 55.4% (P = 0.002). The 5-year OS rates according to the histological malignancy grade were: low grade: 100%; intermediate grade: 83.3%; and high grade: 53.2% (P < 0.001). St IV and high malignancy grade were predictive of an unfavorable prognosis. The treatment results of this study are mostly consistent with those reported previously.